jandekkers schreef op 23 juni 2017 05:35:
Accelerated approval for Pharming possible ? NEW YORK, NY / ACCESSWIRE / June 21, 2017 / The Biotech Industry has continued to outperform the broader markets in 2017. Biotech companies appear to be benefitting from a speedier FDA approval process in 2017. There have already been 21 new Novel Drug Approvals so far in 2017, compared to just 22 new approvals in all of 2016.The iShares NASDAQ Biotechnology Index ETF and the SPDR S&P Biotech ETF have posted year-to-date gains of 14.4 and 26.68 percent, respectively, compared to gains of 8.63 percent and 8.85 percent for the Dow Jones Industrial Average and the S&P 500 Index.